NEW YORK (GenomeWeb News) – BioTrove has filed with the US Securities and Exchange Commission to offer an undetermined number of its shares in an initial public offering.
 
The preliminary prospectus for the IPO did not provide an estimated range for the offering price. BioTrove expects to float on the Nasdaq and trade under the symbol “BTRV.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.